Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Kirn currently holds 565,417 shares of 4D Molecular Therapeutics, Inc. (FDMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Kirn has been a net seller of FDMT stock. They have purchased $0 and sold $8.3M worth of shares.
David Kirn's most recent insider trade was on Jul 10, 2024, when they sold 11,653 shares at $0.00 per share.
David Kirn serves as Executive at 4D Molecular Therapeutics, Inc. (FDMT). They have executed 26 insider transactions totaling $8.3M over their tenure at the company.
David Kirn holds the position of Executive at 4D Molecular Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
David Kirn has shown a selling trading pattern, with $0 in total purchases and $8.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Kirn was on Feb 8, 2024, when they sold $2.5M worth of FDMT shares. This transaction involved 92,001 shares at $27.13 per share.
David Kirn currently owns 565,417 shares of 4D Molecular Therapeutics, Inc. (FDMT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Kirn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Kirn has 26 Form 4 filings on record as an insider at 4D Molecular Therapeutics, Inc..
Set alerts for David Kirn and 40,000+ other insiders.